Deficiency of SPARC suppresses intestinal tumorigenesis in APC(Min/+) mice

Sansom, O. , Mansergh, F., Evans, M., Wilkins, J. and Clarke, A. (2007) Deficiency of SPARC suppresses intestinal tumorigenesis in APC(Min/+) mice. Gut, 56(10), pp. 1410-1414. (doi: 10.1136/gut.2006.116921)

Full text not currently available from Enlighten.


Background and aims: SPARC (secreted protein acidic, rich in cysteine) is a matricellular protein that has been found to be activated in a number of human cancers. More recently, it has been shown to be upregulated in human gastric and colorectal cancer. We therefore wished to address the functional importance of SPARC upregulation to intestinal tumorigenesis in vivo. Methods: SPARC upregulation was determined in intestinal adenomas of tumour-prone Apc(Min/+) mice at both the RNA and the protein level. To determine the functional importance of SPARC for intestinal tumorigenesis we then intercrossed Sparc knockout mice with Apc(Min/+) mice (n = 20). Intestinal enterocyte migration was examined using bromodeoxyuridine labelling studies. Results: Levels of murine Sparc and several related proteins were upregulated in adenomas arising in Apc(Min/) (+) mice. A deficiency of Sparc strongly suppressed adenoma formation in Apc(Min/+) mice (p > = 0.0001). Importantly, a deficiency of Sparc also accelerated enterocyte migration (p = 0.01), as perturbed slow epithelial migration may underpin adenoma formation in the intestine. Conclusions: These data implicate Sparc in both cell migration and tumour formation, and identify Sparc as a potential therapeutic target for colorectal cancer.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Sansom, Professor Owen
Authors: Sansom, O., Mansergh, F., Evans, M., Wilkins, J., and Clarke, A.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Gut

University Staff: Request a correction | Enlighten Editors: Update this record